Oaktree Acquisition Corp. III Life Sciences (OACC) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Shell Companies industria. La empresa tiene su sede en Los Angeles, CA, United States. El CEO actual es Mathew Pendo.
OACC tiene fecha de IPO 2024-12-16, 3 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $263.04M.
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
